Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of 2% Atorvastatin Cream Versus 0.02% Triamcinolone Acetonide Cream in Adults with Facial Seborrheic Dermatitis
TCTR20260204001Phase 2Not yet recruiting
- Sponsor
- Walailak University
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in seborrheic dermatitis (SD) comparing 2% atorvastatin cream with 0.02% triamcinolone acetonide cream (2 arms). Planned start Mar 2026; status: not yet recruiting.
02
Drugs
atorvastatintriamcinolone acetonide
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on TCTR20260204001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260204001.